289 related articles for article (PubMed ID: 18343239)
1. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy.
Hochhaus G
Clin Ther; 2008 Jan; 30(1):1-13. PubMed ID: 18343239
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
Karaki M; Akiyama K; Mori N
Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
[TBL] [Abstract][Full Text] [Related]
4. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate.
van Drunen C; Meltzer EO; Bachert C; Bousquet J; Fokkens WJ
Allergy; 2005; 60 Suppl 80():5-19. PubMed ID: 15948774
[TBL] [Abstract][Full Text] [Related]
5. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.
Derendorf H; Meltzer EO
Allergy; 2008 Oct; 63(10):1292-300. PubMed ID: 18782107
[TBL] [Abstract][Full Text] [Related]
7. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis.
Davies RJ; Nelson HS
Clin Ther; 1997; 19(1):27-38; discussion 2-3. PubMed ID: 9083706
[TBL] [Abstract][Full Text] [Related]
8. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.
Schenkel EJ; Skoner DP; Bronsky EA; Miller SD; Pearlman DS; Rooklin A; Rosen JP; Ruff ME; Vandewalker ML; Wanderer A; Damaraju CV; Nolop KB; Mesarina-Wicki B
Pediatrics; 2000 Feb; 105(2):E22. PubMed ID: 10654982
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials.
Dibildox J
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S54-8. PubMed ID: 11449207
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis].
Klossek JM
Rev Laryngol Otol Rhinol (Bord); 2007; 128(3):187-92. PubMed ID: 18323331
[TBL] [Abstract][Full Text] [Related]
11. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis.
Small CB; Stryszak P; Danzig M; Damiano A
J Allergy Clin Immunol; 2008 Apr; 121(4):928-32. PubMed ID: 18234321
[TBL] [Abstract][Full Text] [Related]
12. Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis.
Berger WE; Nayak AS; Staudinger HW
Ann Pharmacother; 2005 Dec; 39(12):1984-9. PubMed ID: 16278257
[TBL] [Abstract][Full Text] [Related]
13. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same?
Yawn B
MedGenMed; 2006 Jan; 8(1):23. PubMed ID: 16915153
[TBL] [Abstract][Full Text] [Related]
14. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
15. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis.
Bielory L; Chun Y; Bielory BP; Canonica GW
Allergy; 2011 May; 66(5):686-93. PubMed ID: 21261661
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis.
Meltzer EO; Berger WE; Berkowitz RB; Bronsky EA; Dvorin DJ; Finn AF; Galant SP; Grossman J; Hampel FC; Ratner PH; Ruff ME; Schenkel EJ; Segal AT; Segall N; Stewart GE; Tripathy I; Skoner DP; Anolik R; Dockhorn RJ; van Bavel J; Mesarina-Wicki B; Nolop K
J Allergy Clin Immunol; 1999 Jul; 104(1):107-14. PubMed ID: 10400847
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of mometasone furoate nasal spray in seasonal allergic rhinitis. First experiences in practice after the introduction of the drug in Hungary].
Farkas H; Pintér J; Kalabay L; Jakab L; Visy B; Fekete B
Orv Hetil; 2002 Aug; 143(33):1929-33. PubMed ID: 12244656
[TBL] [Abstract][Full Text] [Related]
18. No mucosal atrophy and reduced inflammatory cells: active-controlled trial with yearlong fluticasone furoate nasal spray.
Fokkens WJ; Rinia B; van Drunen CM; Hellings PW; Hens G; Jansen A; Blom H; Wu W; Clements DS; Lee LA; Philpot EE
Am J Rhinol Allergy; 2012; 26(1):36-44. PubMed ID: 22391079
[TBL] [Abstract][Full Text] [Related]
19. [Effectiveness and tolerability of the glucocorticoid mometasone furoate given as nasal spray in seasonal allergic rhinitis].
Magyar P; Herjavecz I; Hirschberg A; Kraszkó P; Mohácsi E; Nékám K; Fónay K; Berta G; Györi Z; Márk Z
Orv Hetil; 2000 Jun; 141(25):1407-11. PubMed ID: 10934885
[TBL] [Abstract][Full Text] [Related]
20. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis.
Meltzer EO; Bardelas J; Goldsobel A; Kaiser H
Treat Respir Med; 2005; 4(4):289-96. PubMed ID: 16086602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
